Skip to main content

Advertisement

SpringerLink
Log in

Neural tube defects: a review of global prevalence, causes, and primary prevention

  • Case-based Review
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Neural tube defects (NTDs) are common birth defects and contribute to life-long disabilities, high medical care costs, and perinatal and child mortality. This review is a primer on prevalence, causes, and evidence-based prevention strategies for NTDs. The estimated average global prevalence of NTDs is two cases per 1000 births, amounting to approximately 214,000–322,000 affected pregnancies worldwide annually. Prevalence and associated adverse outcomes are disproportionately high in developing countries. NTDs have multiple risk factors including genetic and non-genetic (i.e., maternal nutritional status, pre-pregnancy diabetes, early pregnancy exposure to valproic acid (anti-epileptic medication), and a previous pregnancy affected by a NTD) factors. Maternal folate insufficiency before and during early pregnancy is the most common risk factor and is preventable. Folic acid (vitamin B9) is required for formation of the neural tube early in pregnancy, around 28 days after conception, when most women are unaware of their pregnancies. Current guidelines recommend that all women planning or capable of pregnancy take a daily supplement containing 400–800 μg of folic acid. Mandatory folic acid fortification of staple foods (e.g., wheat flour, maize flour, rice) is safe, economical, and the effective intervention for primary prevention of NTDs. Currently, about 60 countries are implementing mandatory folic acid fortification of staple foods, preventing just a quarter of all preventable NTD cases worldwide. There is an urgent need for active champions, including neurosurgeons and other healthcare providers, to generate political will and promote effective mandatory food fortification with folic acid, and reach equitable primary prevention of NTDs in all countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Avagliano L, Massa V, George TM, Qureshy S, Bulfamante GP, Finnell RH (2019) Overview on neural tube defects: from development to physical characteristics. Birth Defects Res 111(19):1455–1467

    Article  CAS  PubMed  Google Scholar 

  2. Greene ND, Copp AJ (2014) Neural tube defects. Annu Rev Neurosci 37:221–242

  3. Cameron M, Moran P (2009) Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 29(4):402–411

    Article  PubMed  Google Scholar 

  4. Blount JP, Bowman R, Dias MS, Hopson B, Partington MD, Rocque BG (2020) Neurosurgery guidelines for the care of people with spina bifida. J Pediatr Rehabil Med 13(4):467–477

    Article  PubMed  PubMed Central  Google Scholar 

  5. Liu T, Ouyang L, Thibadeau J, Wiener JS, Routh JC, Castillo H, Castillo J, Freeman KA, Sawin KJ, Smith K, Van Speybroeck A, Valdez R (2018) Longitudinal study of bladder continence in patients with spina bifida in the National Spina Bifida Patient Registry. J Urol 199(3):837–843

    Article  PubMed  Google Scholar 

  6. Lo A, Polšek D, Sidhu S (2014) Estimating the burden of neural tube defects in low- and middle-income countries. J Glob Health 4(1):010402

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sawin KJ, Margolis RHF, Ridosh MM, Bellin MH, Woodward J, Brei TJ, Logan LR (2021) Self-management and spina bifida: a systematic review of the literature. Disabil Health J 14(1):100940

    Article  PubMed  Google Scholar 

  8. Dewan MC, Wellons JC (2019) Fetal surgery for spina bifida. J Neurosurg Pediatr 24(2):105–114

    Article  PubMed  Google Scholar 

  9. Rofail D, Maguire L, Kissner M, Colligs A, Abetz-Webb L (2013) A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers. Neurol Ther 2(1–2):1–12

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hoddinott J (2018) The investment case for folic acid fortification in developing countries. Ann N Y Acad Sci 1414(1):72–81

    Article  PubMed  PubMed Central  Google Scholar 

  11. Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B (2018) Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci 1414(1):31–46

    Article  PubMed  Google Scholar 

  12. World Health Organization (WHO) (2010) 63rd World Health Assembly. Agenda item 11.7: birth defects. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R17-en.pdf. Accessed 28 Jul 2022

  13. Melo DG, Sanseverino MTV, Schmalfuss TO, Larrandaburu M (2021) Why are birth defects surveillance programs important? Front Public Health 2(9):753342

    Article  Google Scholar 

  14. WHO (2020) Centers for Disease Control and Prevention, International Clearinghouse for Birth Defects. Birth defects surveillance: a manual for programme managers, second edn. Geneva: World Health Organization

  15. Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J (2016) Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLoS ONE 11(4):e0151586

    Article  PubMed  PubMed Central  Google Scholar 

  16. Birth defects surveillance (2020) A manual for programme managers, second edition. Geneva: World Health Organization; Licence: CC BY-NC-SA 3.0 IGO

  17. Christianson A, Howson CP, Modell B (2006) March of Dimes global report on birth defects: the hidden toll of dying and disabled children. White Plains, NY: March of Dimes

  18. Thibadeau J (2017) The National Spina Bifida Patient Registry: past, present, and future. J Pediatr Rehabil Med 10(3–4):205–210

    Article  PubMed  PubMed Central  Google Scholar 

  19. Botto LD, Mastroiacovo P (2018) Triple surveillance: a proposal for an integrated strategy to support and accelerate birth defect prevention. Ann N Y Acad Sci 1414(1):126–136

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bermejo-Sánchez E, Botto LD, Feldkamp ML, Groisman B, Mastroiacovo P (2018) Value of sharing and networking among birth defects surveillance programs: an ICBDSR perspective. J Community Genet 9(4):411–415

    Article  PubMed  PubMed Central  Google Scholar 

  21. WHO (2022) Guideline: fortification of wheat flour with vitamins and minerals as a public health strategy. Geneva: World Health Organization, 2022. License: CC BY-NC-SA 3.0 IGO. https://www.who.int/publications/i/item/9789240043398. Accessed 9 Aug 2021

  22. Atlaw D, Tekalegn Y, Sahiledengle B, Seyoum K, Solomon D, Gezahegn H, Tariku Z, Tekle Y, Chattu VK (2021) Magnitude and determinants of neural tube defect in Africa: a systematic review and meta-analysis. BMC Pregnancy Childbirth 21(1):426

    Article  PubMed  PubMed Central  Google Scholar 

  23. Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E, Garne E, Gatt M, Haeusler M, Klungsoyr K, Latos-Bielenska A, Lynch C, McDonnell B, Nelen V, Neville AJ, O’Mahony MT, Queisser-Luft A, Rankin J, Rissmann A, Ritvanen A, Rounding C, Sipek A, Tucker D, Verellen-Dumoulin C, Wellesley D, Dolk H (2015) Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 351:h5949

    Article  PubMed  PubMed Central  Google Scholar 

  24. Oumer M, Tazebew A, Silamsaw M (2021) Birth prevalence of neural tube defects and associated risk factors in Africa: a systematic review and meta-analysis. BMC Pediatr 21(1):190

    Article  PubMed  PubMed Central  Google Scholar 

  25. Atta CA, Fiest KM, Frolkis AD, Jette N, Pringsheim T, St Germaine-Smith C, Rajapakse T, Kaplan GG, Metcalfe A (2016) Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health 106(1):e24-34

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yacob A, Carr CJ, Foote J, Scullen T, Werner C, Mathkour M, Bui CJ, Dumont AS (2021) The global burden of neural tube defects and disparities in neurosurgical care. World Neurosurg 149:e803–e820

    Article  PubMed  Google Scholar 

  27. Finnell RH, Caiaffa CD, Kim SE, Lei Y, Steele J, Cao X, Tukeman G, Lin YL, Cabrera RM, Wlodarczyk BJ (2021) Gene environment interactions in the etiology of neural tube defects. Front Genet 12:659612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lupo PJ, Agopian AJ, Castillo H, Castillo J, Clayton GH, Dosa NP, Hopson B, Joseph DB, Rocque BG, Walker WO, Wiener JS, Mitchell LE (2017) Genetic epidemiology of neural tube defects. J Pediatr Rehabil Med 10(3–4):189–194

    Article  PubMed  PubMed Central  Google Scholar 

  29. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991(338):131–137

    Google Scholar 

  30. Liu J, Li Z, Greene NDE, Li H, Ren A (2017) The recurrence risk of neural tube defects (NTDs) in a population with high prevalence of NTDs in northern China. Oncotarget 8(42):72577–72583

    Article  PubMed  PubMed Central  Google Scholar 

  31. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A (1999) Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341(20):1485–1490

  32. Czeizel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327(26):1832–1835

    Article  CAS  PubMed  Google Scholar 

  33. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, Reece EA (2008) Diabetes mellitus and birth defects. Am J Obstet Gynecol 199(3):237.e1–9

    Article  PubMed  Google Scholar 

  34. Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM (2013) The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol 209(3):239.e1–8

    Article  CAS  PubMed  Google Scholar 

  35. Tanoshima M, Kobayashi T, Tanoshima R, Beyene J, Koren G, Ito S (2015) Risks of congenital malformations in offspring exposed to valproic acid in utero: a systematic review and cumulative meta-analysis. Clin Pharmacol Ther 98(4):417–441

    Article  CAS  PubMed  Google Scholar 

  36. Agopian AJ, Tinker SC, Lupo PJ, Canfield MA, Mitchell LE (2013) National birth defects prevention study. Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol 97(1):42–46

  37. Petersen JM, Parker SE, Crider KS, Tinker SC, Mitchell AA, Werler MM (2019) One-carbon cofactor intake and risk of neural tube defects among women who meet folic acid recommendations: a multicenter case-control study. Am J Epidemiol 188(6):1136–1143

    Article  PubMed  PubMed Central  Google Scholar 

  38. National Institute of Health (2019) Folate. Retrieved from https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/#en133. Accessed 29 Jul 2022

  39. Bailey LB, Gregory JF 3rd (1999) Folate metabolism and requirements. J Nutr 129(4):779–782

    Article  CAS  PubMed  Google Scholar 

  40. Institute of Medicine (1998) Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academies Press, Washington (DC)

    Google Scholar 

  41. Crider KS, Yang TP, Berry RJ, Bailey LB (2012) Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr 3(1):21–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ferrazzi E, Tiso G, Di Martino D (2020) Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy. Eur J Obstet Gynecol Reprod Biol 253:312–319

    Article  CAS  PubMed  Google Scholar 

  43. Susser E, Hoek HW, Brown A (1998) Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol 147(3):213–216

    Article  CAS  PubMed  Google Scholar 

  44. Lanska DJ (2010) Chapter 30: Historical aspects of the major neurological vitamin deficiency disorders: the water‐soluble B vitamins. Handb Clin Neurol 95:445–476

  45. Elwood JH, Scott MJ (1982) Prevalence of anencephalus in the United Kingdom. Dev Med Child Neurol 24(3):394–395

    CAS  PubMed  Google Scholar 

  46. Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, Werler MM, Hobbs CA (2009) National birth defects prevention study. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 169(1):9–17

  47. Werler MM, Shapiro S, Mitchell AA (1993) Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269(10):1257–1261

    Article  CAS  PubMed  Google Scholar 

  48. Field MS, Stover PJ (2018) Safety of folic acid. Ann N Y Acad Sci 1414(1):59–71

    Article  PubMed  Google Scholar 

  49. Bailey LB, Caudill MA (2012) Folate. In: Erdman JW, Macdonald IA, & Zeisel SH, eds. Present knowledge in nutrition (pp. 321–342). 10th ed. Washington, DC: Wiley-Blackwell

  50. Chen MY, Rose CE, Qi YP, Williams JL, Yeung LF, Berry RJ, Hao L, Cannon MJ, Crider KS (2019) Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation. Am J Clin Nutr 109(5):1452–1461

    Article  PubMed  Google Scholar 

  51. Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM, Li Z, Zhu J, Berry RJ (2014) Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349:g4554

    Article  PubMed  PubMed Central  Google Scholar 

  52. Cordero AM, Crider KS, Rogers LM, Cannon MJ, Berry RJ (2015) Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep 64(15):421–423

    PubMed  PubMed Central  Google Scholar 

  53. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Silverstein M, Tseng CW (2017) Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. JAMA 317(2):183–189

  54. Bailey LB, Hausman DB (2018) Folate status in women of reproductive age as basis of neural tube defect risk assessment. Ann N Y Acad Sci 1414(1):82–95

    Article  CAS  PubMed  Google Scholar 

  55. Centers for Disease Control and Prevention (2011) Ten great public health achievements--United States, 2001–2010. MMWR Morb Mortal Wkly Rep 60(19):619–623

  56. Castillo-Lancellotti C, Tur JA, Uauy R (2013) Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr 16(5):901–911

    Article  PubMed  Google Scholar 

  57. Centeno Tablante E, Pachón H, Guetterman HM, Finkelstein JL (2019) Fortification of wheat and maize flour with folic acid for population health outcomes. Cochrane Database Syst Rev 7(7):CD012150

  58. Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, De Vigan C, De Walle H, Erickson DJ, Halliday J, Irgens LM, Lowry RB, McDonnell R, Metneki J, Poetzsch S, Ritvanen A, Robert-Gnansia E, Siffel C, Stoll C, Mastroiacovo P (2006) Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 76(10):693–705

    Article  CAS  PubMed  Google Scholar 

  59. Rosenthal J, Reeve ME, Ramirez N, Crider KS, Sniezek J, Vellozzi C, Devine O, Lopez-Pazos E (2016) Red blood cell folate insufficiency among nonpregnant women of childbearing age in Guatemala 2009 to 2010: prevalence and predicted neural tube defects risk. Birth Defects Res A Clin Mol Teratol 106(7):587–595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. D'Antoine H, Bower C (2019) Folate status and neural tube defects in aboriginal Australians: the success of mandatory fortification in reducing a health disparity. Curr Dev Nutr 3(8):nzz071

  61. Gomes S, Lopes C, Pinto E (2016) Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO. Public Health Nutr 19(1):176–189

    Article  PubMed  Google Scholar 

  62. Yeung LF, Cogswell ME, Carriquiry AL, Bailey LB, Pfeiffer CM, Berry RJ (2011) Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children: National Health and Nutrition Examination Survey (NHANES), 2003–2006. Am J Clin Nutr 93(1):172–185

    Article  CAS  PubMed  Google Scholar 

  63. Toivonen KI, Lacroix E, Flynn M et al (2018) Folic acid supplementation during the preconception period: a systematic review and meta-analysis. Prev Med 114:1–17

    Article  CAS  PubMed  Google Scholar 

  64. Shlobin NA, LoPresti MA, Du RY, Lam S (2020) Folate fortification and supplementation in prevention of folate-sensitive neural tube defects: a systematic review of policy. J Neurosurg Pediatr 27:294–310

    Article  PubMed  Google Scholar 

  65. Kancherla V, Wagh K, Priyadarshini P, Pachón H, Oakley GP Jr (2022) A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects. Birth Defects Res 114(20):1392–1403

  66. Wong LY, Paulozzi LJ (2001) Survival of infants with spina bifida: a population study, 1979–94. Paediatr Perinat Epidemiol 15(4):374–378

    Article  CAS  PubMed  Google Scholar 

  67. Bol KA, Collins JS, Kirby RS (2006) National birth defects prevention network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 117(3):803–813

  68. Mai CT, Evans J, Alverson CJ, Yue X, Flood T, Arnold K, Nestoridi E, Denson L, Adisa O, Moore CA, Nance A, Zielke K, Rice S, Shan X, Dean JH, Ethen M, Hansen B, Isenburg J, Kirby RS (2022) Changes in spina bifida lesion level after folic acid fortification in the United States. J Pediatr S0022–3476(22):00597–00602

    Google Scholar 

  69. Pfeiffer CM, Zhang M, Jabbar S (2018) Framework for laboratory harmonization of folate measurements in low- and middle-income countries and regions. Ann N Y Acad Sci 1414(1):96–108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Kancherla V, Roos N, Walani SR (2022) Relationship between achieving Sustainable Development Goals and promoting optimal care and prevention of birth defects globally. Birth Defects Res. https://doi.org/10.1002/bdr2.2055. Epub ahead of print

  71. Kancherla V, Botto LD, Rowe LA, Shlobin NA, Caceres A, Arynchyna-Smith A, Zimmerman K, Blount J, Kibruyisfaw Z, Ghotme KA, Karmarkar S, Fieggen G, Roozen S, Oakley GP Jr, Rosseau G, Berry RJ (2022) Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. Lancet Glob Health 10(7):e1053–e1057

    Article  CAS  PubMed  Google Scholar 

  72. Caceres A, Blount JP, Messing-Jünger M, Chatterjee S, Fieggen G, Salomao JF (2021) The International Society for Pediatric Neurosurgery resolution on mandatory folic acid fortification of staple foods for prevention of spina bifida and anencephaly and associated disability and child mortality. Childs Nerv Syst 37(6):1809–1812

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

I thank Ms. Amanda Dorsey, Graduate Research Assistant, Center for Spina Bifida at Emory University Rollins School of Public Health for proofreading and thoughtful technical comments.

Author information

Authors and Affiliations

  1. Center for Spina Bifida Prevention, Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA

    Vijaya Kancherla

Authors
  1. Vijaya Kancherla
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Vijaya Kancherla has contributed to the manuscript solely, and drafted both the manuscript and Fig. 1.

Corresponding author

Correspondence to Vijaya Kancherla.

Ethics declarations

Conflict of interest

There are no competing interests to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kancherla, V. Neural tube defects: a review of global prevalence, causes, and primary prevention. Childs Nerv Syst 39, 1703–1710 (2023). https://doi.org/10.1007/s00381-023-05910-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-023-05910-7

Keywords

Search

Navigation